Lundbeck
HLUN-B.CO
#2786
Rank
A$7.21 B
Marketcap
$7.48
Share price
0.77%
Change (1 day)
-0.96%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Market capitalization of Lundbeck (HLUN-B.CO)

Market cap: A$7.21 Billion

As of May 2025 Lundbeck has a market cap of A$7.21 Billion. This makes Lundbeck the world's 2786th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lundbeck from 2005 to 2025

End of year Market Cap

Year Marketcap Change
2025A$7.21 B-19.51%
2024A$8.96 B29.78%
2023A$6.90 B30%
2022A$5.31 B460.61%
2021A$0.94 B-20.96%
2020A$1.19 B-17.27%
2019A$1.44 B-12.3%
2018A$1.65 B-4.53%
2017A$1.73 B15%
2016A$1.50 B20.2%
2015A$1.25 B93.71%
2014A$0.64 B-13.59%
2013A$0.74 B101.12%
2012A$0.37 B-42.27%
2011A$0.64 B31.64%
2010A$0.48 B-10.51%
2009A$0.54 B-35.92%
2008A$0.85 B1.88%
2007A$0.83 B-14.64%
2006A$0.98 B15.97%
2005A$0.84 B

End of Day market cap according to different sources

On Apr 30th, 2025 the market cap of Lundbeck was reported to be:

A$7.19 Billion
by Yahoo Finance info icon info icon
A$7.19 Billion
by CompaniesMarketCap info icon info icon